Recurrent Inflammatory Breast Carcinoma
Also known as: Recurrent Breast Inflammatory Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB15121 | AT-001 | 1 / 2 | Active Not Recruiting | 1 |
| DB08871 | Eribulin | 1 / 2 | Active Not Recruiting | 1 |
| DB12836 | Grapiprant | 1 / 2 | Active Not Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
| DB05239 | Cobimetinib | 2 | Active Not Recruiting | 1 |
| DB08871 | Eribulin | 2 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Terminated | 1 |
| DB06132 | Nivolumab | 2 | Terminated | 1 |
| DB09035 | Nivolumab | 2 | Terminated | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB13896 | Talimogene laherparepvec | 2 | Terminated | 1 |